27 results
8-K
EX-99.2
46laid u7tmm5rgwvci
8 Aug 22
REATA PHARMACEUTICALS, INC. ANNOUNCES Second QUARTER 2022 FINANCIAL
6:45am
8-K
EX-99.1
iri02fd
1 Mar 21
Reata pharmaceuticals, inc. announces FOURTH quarter AND FULL YEAR 2020 financial RESULTS and provides an update on CLINICAL DEVELOPMENT programs
6:40am
8-K
EX-99.1
u2e4ibb5z11poy
11 Jan 21
Regulation FD Disclosure
6:30am
424B5
6ttu0p3nb2wtlrc 8r86
3 Dec 20
Prospectus supplement for primary offering
4:41pm
424B5
fak hirz8rywk
1 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
k8i8skg1 dgc5x9nl
9 Nov 20
Vinny Jindal; Reata Pharmaceuticals Inc.; VP of Strategy
5:30pm
8-K
EX-99.3
dp62y7pat 5k1a4
9 Nov 20
Reported positive year 2 data from the pivotal CARDINAL study of bardoxolone methyl in patients with chronic kidney disease caused by Alport syndrome
6:51am